Medicine
Cyclobenzaprine 7.5 mg tablet
Cyclobenzaprine 7.5 mg tablet is a generic prescription medicine for oral use, made by 24 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20º to 25°C (68º to 77°F).
Key facts
- Active ingredient (INN)
- Cyclobenzaprine
- Brand
- Sold under the generic name
- Strength
- 7.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 30 tablets and 115 more
- Manufacturers
- Jubilant Cadista PharmaceuticalsIndiaAlembic PharmaceuticalsIndiaUnichem LaboratoriesIndiaAsclemedSa3Advagen PharmaAiPing PharmaceuticalCoral Way PharmaTeva PharmaceuticalsTruPharma24 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20º to 25°C (68º to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M03BX08 Cyclobenzaprine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 March 2015
- Identifiers
- RxCUI 828299, 828320, 828348DailyMed set ID 3a397e88-d267-feed-e063-6294a90a7710, ae3a3f5c-fb64-4a43-be88-a2fc7c298ac1, 1d9e34cc-eee9-4147-abf8-c810a80e39d2 +29NDC 85509-1001, 63187-590, 0093-3421 +29Application ANDA078722, ANDA071611, ANDA213324 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 24 labelers. The register lists 118 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 62332-649-31 | Alembic PharmaceuticalsIndia | 4 November 2020 |
| 1000 tablet, film coated in 1 bottle | 62332-649-91 | Alembic PharmaceuticalsIndia | 4 November 2020 |
| 100 tablet, film coated in 1 bottle | 59746-735-01 | Jubilant Cadista PharmaceuticalsIndia | 9 October 2017 |
| 1000 tablet, film coated in 1 bottle | 59746-735-10 | Jubilant Cadista PharmaceuticalsIndia | 9 October 2017 |
| 30 tablet, film coated in 1 bottle | 59746-735-30 | Jubilant Cadista PharmaceuticalsIndia | 9 October 2017 |
| 100 tablet, film coated in 1 bottle | 29300-414-01 | Unichem LaboratoriesIndia | 30 September 2020 |
| 1000 tablet, film coated in 1 bottle | 29300-414-10 | Unichem LaboratoriesIndia | 30 September 2020 |
| 100 tablet, film coated in 1 bottle | 72888-013-01 | Advagen Pharma | 31 May 2017 |
| 100 tablet, film coated in 1 bottle | 11788-094-01 | AiPing Pharmaceutical | 23 October 2026 |
| 1000 tablet, film coated in 1 bottle | 85437-013-10 | Coral Way Pharma | 4 October 2026 |
| 1000 tablet, film coated in 1 bottle | 69420-1001-1 | Sa3 | 25 March 2015 |
| 100 tablet, film coated in 1 bottle | 69420-1001-2 | Sa3 | 25 March 2015 |
| 30 tablet, film coated in 1 bottle | 69420-1001-3 | Sa3 | 25 March 2015 |
| 100 tablet, film coated in 1 bottle | 0093-3421-01 | Teva Pharmaceuticals | 20 July 2021 |
| 100 tablet, film coated in 1 bottle | 52817-331-10 | TruPharma | 31 May 2017 |
| 100 tablet, film coated in 1 bottle | 76420-010-01 | Asclemed | 21 October 2022 |
| 500 tablet, film coated in 1 bottle | 76420-010-05 | Asclemed | 21 October 2022 |
| 120 tablet, film coated in 1 bottle | 76420-010-12 | Asclemed | 16 March 2023 |
| 15 tablet, film coated in 1 bottle | 76420-010-15 | Asclemed | 21 October 2022 |
| 30 tablet, film coated in 1 bottle | 76420-010-30 | Asclemed | 23 January 2020 |
| 60 tablet, film coated in 1 bottle | 76420-010-60 | Asclemed | 23 January 2020 |
| 90 tablet, film coated in 1 bottle | 76420-010-90 | Asclemed | 21 October 2022 |
| 100 tablet, film coated in 1 bottle | 76420-256-30 | Asclemed | 19 July 2022 |
| 60 tablet, film coated in 1 bottle | 76420-256-60 | Asclemed | 19 July 2022 |
| 90 tablet, film coated in 1 bottle | 76420-256-90 | Asclemed | 19 July 2022 |
| 100 tablet, film coated in 1 bottle | 76420-265-10 | Asclemed | 1 September 2022 |
| 30 tablet, film coated in 1 bottle | 76420-265-30 | Asclemed | 1 September 2022 |
| 60 tablet, film coated in 1 bottle | 76420-265-60 | Asclemed | 1 September 2022 |
| 90 tablet, film coated in 1 bottle | 76420-265-90 | Asclemed | 1 September 2022 |
| 1 tablet, film coated in 1 bottle | 76420-268-01 | Asclemed | 3 September 2022 |
| 2 tablet, film coated in 1 bottle | 76420-268-02 | Asclemed | 3 September 2022 |
| 7 tablet, film coated in 1 bottle | 76420-268-07 | Asclemed | 3 September 2022 |
| 100 tablet, film coated in 1 bottle | 76420-268-10 | Asclemed | 3 September 2022 |
| 15 tablet, film coated in 1 bottle | 76420-268-15 | Asclemed | 3 September 2022 |
| 20 tablet, film coated in 1 bottle | 76420-268-20 | Asclemed | 3 September 2022 |
| 30 tablet, film coated in 1 bottle | 76420-268-30 | Asclemed | 3 September 2022 |
| 60 tablet, film coated in 1 bottle | 76420-268-60 | Asclemed | 3 September 2022 |
| 90 tablet, film coated in 1 bottle | 76420-268-90 | Asclemed | 3 September 2022 |
| 100 tablet, film coated in 1 bottle | 76420-829-01 | Asclemed | 2 July 2024 |
| 7 tablet, film coated in 1 bottle | 76420-829-07 | Asclemed | 4 February 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 26 August 1977 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Cyclobenzaprine 7.5 mg tablet.
Other strengths and forms of Cyclobenzaprine
Clinical summary
Cyclobenzaprine is a muscle relaxant indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. MedsAcross supplies Cyclobenzaprine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CyclobenzaprineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cyclobenzaprine Hydrochloride prescribing information (Amneal Pharmaceuticals of New York) · U.S. National Library of Medicine, DailyMed
Need Cyclobenzaprine 7.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.